Answer
No. It is substrate-reduction therapy that decreases production of certain glycosphingolipids.
Sources for this answer
- Yargesa (miglustat) 100mg Hard Capsules — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.